Drug Profile
Anti-CD4 monoclonal antibody GK1-5
Latest Information Update: 17 Nov 2003
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Royal Melbourne Hospital; University of Iowa
- Class Monoclonal antibodies
- Mechanism of Action CD4 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus; Rheumatic disorders; Transplant rejection